Showing results (161-170 of 264) with videos related to

Sort By:
Pageof 27
Journal of Affective Disorders|November 10, 2015
Resting-state functional network connectivity in prefrontal regions differs between unmedicated patients with bipolar and major depressive disordersHao He, Qingbao Yu, Yuhui Du, et al.
Bipolar Disorders|October 9, 2018
Cluster analysis with MOODS-SR illustrates a potential bipolar disorder risk phenotype in young adults with remitted major depressive disorderLeah R Kling, Katie L Bessette, Sophie R DelDonno, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2002
Sequential H(2)(15)O PET studies in baboons: before and after amphetamineJulie C Price, Wayne C Drevets, James Ruszkiewicz, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|March 9, 2025
Effect of Esketamine on Depressive Symptoms in Adolescents With Major Depressive Disorder at Imminent Suicide Risk: A Randomized Psychoactive-Controlled StudyColette Kosik-Gonzalez, Dong-Jing Fu, Li Nancy Chen, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 26, 2016
Efficacy and safety of an adjunctive mGlu2 receptor positive allosteric modulator to a SSRI/SNRI in anxious depressionJustine M Kent, Ella Daly, Iva Kezic, et al.
Scientific Reports|March 10, 2012
Effects of arterial cannulation stress on regional cerebral blood flow in major depressive disorderJonathan Savitz, Allison C Nugent, Dara M Cannon, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 23, 2004
Reduced serotonin type 1A receptor binding in panic disorderAlexander Neumeister, Earle Bain, Allison C Nugent, et al.
The International Journal of Eating Disorders|January 29, 2013
Executive function in eating disorders: the role of state anxietyRebecca L Billingsley-Marshall, Michael R Basso, Brian C Lund, et al.
Brain, Behavior, and Immunity|February 18, 2015
Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorderJonathan Savitz, Wayne C Drevets, Brent E Wurfel, et al.
The International Journal of Neuropsychopharmacology|November 8, 2024
Effect of Esketamine Nasal Spray on Cognition in Patients With Treatment-Resistant Depression: Results From Four Phase 3 StudiesRandall L Morrison, Jaskaran Singh, Ella Daly, et al.
Pageof 27